Cargando…
Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
Oral mucositis (OM) is a common complication of cancer therapy, however OM management remains unsatisfactory. There is a growing interest in the therapeutic potential of probiotics in OM due to positive findings of its use in intestinal mucositis. This study aimed to determine the efficacy and safet...
Autores principales: | Gupta, Nitasha, Ferreira, Joao, Hong, Catherine Hsu Ling, Tan, Kai Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530769/ https://www.ncbi.nlm.nih.gov/pubmed/33004948 http://dx.doi.org/10.1038/s41598-020-73292-w |
Ejemplares similares
-
Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients
por: Alforaidi, Sahal, et al.
Publicado: (2021) -
The use of Lactobacillus reuteri DSM 17938 and ATCC
PTA 5289 on oral health indexes in a school population: A pilot randomized
clinical trial
por: Borrell García, Carla, et al.
Publicado: (2021) -
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial
por: Romani Vestman, Nelly, et al.
Publicado: (2015) -
Orodispersible lozenges containing a combination of Lactobacillus reuteri
DSM 17938 and Lactobacillus reuteri
ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2020) -
Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor
por: Dore, Maria Pina, et al.
Publicado: (2019)